Chinese cancer genetic testing service company Geneseeq has raised RMB800 million (US$114.3 million) in a series D round of financing led by China Reform Holdings Corporation.
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription? Log in
